Unique ID issued by UMIN | UMIN000042832 |
---|---|
Receipt number | R000048874 |
Scientific Title | Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes. |
Date of disclosure of the study information | 2020/12/25 |
Last modified on | 2020/12/24 10:52:25 |
Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.
Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.
Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.
Predictive factors during the postpartum period for glucose intolerance in women with gestational diabetes.
Japan |
Gestational diabetes
Endocrinology and Metabolism |
Others
NO
To investigate the risk factors for glucose intolerance in women with GDM.
Others
The purpose of this study was to investigate the predictive factor during the postpartum period for glucose intolerance in women with GDM at a singles perinatal center in Japan by comparing the various factors between the patients with normal glucose tolerance and glucose intolerance.
The risk factors for glucose intolerance in women with GDM during the postpartum period
1) Patient's basic information: age, pre-pregnancy BMI, and previous pregnancy
2) Gestational history of pregnancy and delivery: 75 g OGTT results, weight gain, number of days in pregnancy, maternal perinatal complications
3) Clinical information on the child: child weight, neonatal complications, and Apgar score
4) Treatment: insulin unit count
5) Postpartum information: postpartum 75gOGTT results
6) Patient's medical record information: Family history of diabetes
Observational
Not applicable |
Not applicable |
Female
Patients who were diagnosed with GDM between January 1 2015 and May 31 2020 at Yokohama Medical Center, and who had glucose tolerance test within postpartum period.
Patients were excluded if they had; no measurement for insulin at the postpartum OGTT, been treated with steroid, or overt diabetes.
250
1st name | Kazuki |
Middle name | |
Last name | Tajima |
Yokohama Medical Center
Department of endocrinology & metabolism
245-8575
3-60-2 Harajuku, Totsuka-ku, Yokohama
045-851-2621
tajima.kazuki.jn@mail.hosp.go.jp
1st name | Kazuki |
Middle name | |
Last name | Tajima |
Yokohama Medical Center
Department of endocrinology & metabolism
245-8575
3-60-2 Harajuku, Totsuka-ku, Yokohama
045-851-2621
tajima.kazuki.jn@mail.hosp.go.jp
Yokohama Medical Center
This research will be funded by the basic research funds of the department to which the principal investigator belongs.
Self funding
Yokohama Medical Center, Clinical Trial Management Office
3-60-2 Harajuku, Totsuka-ku, Yokohama
045-851-2621
700-kenkyu@mail.hosp.go.jp
NO
2020 | Year | 12 | Month | 25 | Day |
Unpublished
Preinitiation
2020 | Year | 09 | Month | 02 | Day |
2020 | Year | 09 | Month | 02 | Day |
2020 | Year | 12 | Month | 26 | Day |
2021 | Year | 12 | Month | 31 | Day |
This is a retrospective observational study using existing medical record information from routine practice, and no burden or risk is expected to arise from participation in this study. The results of the study may be beneficial for future advances in the management of gestational diabetes mellitus.
2020 | Year | 12 | Month | 24 | Day |
2020 | Year | 12 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048874
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |